The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Allergan Inc

NYSE: AGN
Last

(U.S.) $211.95

Today's change+1.83 +0.87%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Allergan Inc

NYSE: AGN
Last

(U.S.) $211.95

Today's change+1.83 +0.87%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Allergan Inc crosses above 20-day moving average

Allergan Inc closed up Friday by (U.S.)$1.83 or 0.87% to (U.S.)$211.95 and crossing above its 20-day moving average. Shares have lost 0.32% over the last five days, but sit 1.26% below their 52-week high. This security has outperformed the S&P 500 by 79.46% during the last year.

Key company metrics

  • Open(U.S.) $210.98
  • Previous close(U.S.) $210.12
  • High(U.S.) $211.99
  • Low(U.S.) $210.19
  • Bid / Ask-- / --
  • YTD % change+90.81%
  • Volume756,827
  • Average volume (10-day)2,455,864
  • Average volume (1-month)2,211,812
  • Average volume (3-month)3,098,736
  • 52-week range(U.S.) $108.31 to (U.S.) $214.66
  • Beta0.75
  • Trailing P/E49.40×
  • P/E 1 year forward33.64×
  • Forward PEG1.56×
  • Indicated annual dividend(U.S.) $0.20
  • Dividend yield0.09%
  • Trailing EPS(U.S.) $4.29
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.58%

Based on its net profit margin of 18.58%, Allergan Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,8171,8641,6461,684
Total other revenue--------
Total revenue1,8171,8641,6461,684
Gross profit1,6111,6421,4421,480
Total cost of revenue207222205205
Total operating expense1,4241,2561,2641,230
Selling / general / administrative715719659619
Research & development289289349262
Depreciation / amortization29282828
Interest expense (income), net operating--------
Unusual expense (income)186-224116
Other operating expenses, total--------
Operating income393608382455
Interest income (expense), net non-operating-18-20-16-18
Gain (loss) on sale of assets--------
Other--------
Income before tax419574362441
Income after tax313418259313
Income tax, total106156103128
Net income313417257313
Total adjustments to net income--------
Net income before extra. items312417258313
Minority interest-1-1-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items312417258313
Inc. avail. to common incl. extra. items313417257313
Diluted net income313417257313
Dilution adjustment----0--
Diluted weighted average shares303304304302
Diluted EPS excluding extraordinary itemsvalue per share1.031.370.851.04
Dividends per sharevalue per share0.050.050.050.05
Diluted normalized EPSvalue per share1.491.370.911.31